Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial

Meghan Karuturi, Anas Younes, Luis Fayad, Larry Kwak, Barbara Pro, Jatin Shah, Yasuhiro Oki, Rinata Simien, Mary Joy Liboon, Toni Hutto, Lei Feng, Sandra Horowitz, Yago Nieto, Paolo Anderlini, Amin Alousi, Uday Popat, L. Jeffrey Medeiros, Roberto Miranda, Michelle Fanale

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)445-447
Number of pages3
JournalLeukemia and Lymphoma
Volume57
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Ifosfamide
Carboplatin
Etoposide
Hodgkin Disease
Bortezomib

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Karuturi, Meghan ; Younes, Anas ; Fayad, Luis ; Kwak, Larry ; Pro, Barbara ; Shah, Jatin ; Oki, Yasuhiro ; Simien, Rinata ; Liboon, Mary Joy ; Hutto, Toni ; Feng, Lei ; Horowitz, Sandra ; Nieto, Yago ; Anderlini, Paolo ; Alousi, Amin ; Popat, Uday ; Medeiros, L. Jeffrey ; Miranda, Roberto ; Fanale, Michelle. / Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma : Results of a randomized phase II trial. In: Leukemia and Lymphoma. 2016 ; Vol. 57, No. 2. pp. 445-447.
@article{7cf4bcd145904e64a373988f96fe2ad2,
title = "Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial",
author = "Meghan Karuturi and Anas Younes and Luis Fayad and Larry Kwak and Barbara Pro and Jatin Shah and Yasuhiro Oki and Rinata Simien and Liboon, {Mary Joy} and Toni Hutto and Lei Feng and Sandra Horowitz and Yago Nieto and Paolo Anderlini and Amin Alousi and Uday Popat and Medeiros, {L. Jeffrey} and Roberto Miranda and Michelle Fanale",
year = "2016",
month = "2",
day = "1",
doi = "10.3109/10428194.2015.1032966",
language = "English (US)",
volume = "57",
pages = "445--447",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "2",

}

Karuturi, M, Younes, A, Fayad, L, Kwak, L, Pro, B, Shah, J, Oki, Y, Simien, R, Liboon, MJ, Hutto, T, Feng, L, Horowitz, S, Nieto, Y, Anderlini, P, Alousi, A, Popat, U, Medeiros, LJ, Miranda, R & Fanale, M 2016, 'Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial' Leukemia and Lymphoma, vol. 57, no. 2, pp. 445-447. https://doi.org/10.3109/10428194.2015.1032966

Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma : Results of a randomized phase II trial. / Karuturi, Meghan; Younes, Anas; Fayad, Luis; Kwak, Larry; Pro, Barbara; Shah, Jatin; Oki, Yasuhiro; Simien, Rinata; Liboon, Mary Joy; Hutto, Toni; Feng, Lei; Horowitz, Sandra; Nieto, Yago; Anderlini, Paolo; Alousi, Amin; Popat, Uday; Medeiros, L. Jeffrey; Miranda, Roberto; Fanale, Michelle.

In: Leukemia and Lymphoma, Vol. 57, No. 2, 01.02.2016, p. 445-447.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma

T2 - Results of a randomized phase II trial

AU - Karuturi, Meghan

AU - Younes, Anas

AU - Fayad, Luis

AU - Kwak, Larry

AU - Pro, Barbara

AU - Shah, Jatin

AU - Oki, Yasuhiro

AU - Simien, Rinata

AU - Liboon, Mary Joy

AU - Hutto, Toni

AU - Feng, Lei

AU - Horowitz, Sandra

AU - Nieto, Yago

AU - Anderlini, Paolo

AU - Alousi, Amin

AU - Popat, Uday

AU - Medeiros, L. Jeffrey

AU - Miranda, Roberto

AU - Fanale, Michelle

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84955179441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955179441&partnerID=8YFLogxK

U2 - 10.3109/10428194.2015.1032966

DO - 10.3109/10428194.2015.1032966

M3 - Letter

VL - 57

SP - 445

EP - 447

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 2

ER -